Study details
Enrolling now
Ethnic Differences in Mechanisms of Action of Dupilumab
University of Michigan
NCT IDNCT05268107ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
30
Study length
about 4.4 years
Ages
18+
Locations
1 site in MI
About this study
This trial is testing how different ethnic groups respond to the drug dupilumab for atopic dermatitis. The goal is to understand if there are differences in how inflammation works in people with AD based on their ethnicity.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Dupilumab
PhasePhase 4
DrugDupilumab
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
dupilumab
Body systems
Dermatology